DNMT3b 39179G → T polymorphism and the risk of adenocarcinoma of the colon in Koreans

Biochemical Genetics

Volumn 45, Issue 3-4, 2007, Pages 155-163

  Hong, Young Seoub ^a   Lee, Hye Jung ^a   You, Chang Hun ^a   Roh, Mee Sook ^a   Kwak, Jong Young ^a   Lee, Myeong Jin ^b   Kim, Joon Youn ^a  

^a Dong A University   (South Korea)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Carcinogenesis; Colon cancer; DNMT3b; Methylation

Indexed keywords

DNA METHYLTRANSFERASE 3B; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNMT3B PROTEIN, HUMAN; GUANINE; THYMINE; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; CANCER PATIENT; CANCER RISK; COLON ADENOCARCINOMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA METHYLATION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK REDUCTION; SEX; ADENOCARCINOMA; ASIAN; CASE CONTROL STUDY; COLON TUMOR; ENZYMOLOGY; GENE FREQUENCY; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENOTYPE; GUANINE; HUMANS; KOREA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; ODDS RATIO; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; THYMINE;

EID: 33947496848     PISSN: 00062928     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10528-006-9047-9     Document Type: Article

References (20)

1. Belinsky, S. A., Nikula, K. J., Baylin, S. B., and Issa, J. P. (1996). Increased cytosine DNA methyltransferase activity is target cell specific and an early event in lung cancer. Proc. Natl. Acad. Sci. 93:4045-4050.
2. Butkiewicz, D., Rusin, M., Enewold, L., Shields, P. G., Chorazy, M., and Harris, C. C. (2001). Genetic polymorphism in DNA repair genes and risk of lung cancer. Carcinogenesis 22:593-597.
3. Eng, C., Herman, J. G., and Baylin, S. B. (2000). A bird's eye view of global methylation. Nat. Getet. 24:101-102.
4. Esteller, M., Corn, P. G., Baylin, S. B., and Herman, J. G. (2001). A gene hypermethylation profile of human cancer. Cancer. Res. 61:3225-3229.
5. Gu, J., Spitz, M. R., Yang, F., and Wu, X. (1999). Ethnic differences in poly(ADP-ribose) polymerase pseudogene genotype distribution and association with lung cancer risk. Carcinogenesis 20:1465-1469.
6. Issa, J. P., Baylin, S. B., and Belinsky, S. A. (1996). Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure. Cancer Res. 56:3655-3658.
7. Lee, S. J., Jeon, H. S., Jang, J. S., Park, S. H., Lee, G. Y., Lee, B. H., Kim, C. H., and Kang, Y. M. (2005). DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 26:403-409.
8. Liu, G., Miller, D. P., Zhou, W., Thurston, S. W., Fan, R., Xu, L. L., Lynch, T. J., Wain, J. C., Su, L., and Christiani, D. C. (2001). Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non small cell lung cancer. Cancer Res. 61:8718-8722.
9. Liu, K., Wang, Y. F., Cantemir, C., and Muller, M. T. (2003). Endogenous assays of DNA methyltransferases: Evidence for differential activities of DNMT1, DNMT2, and DNMT3 in mammalian cells in vivo. Mol. Cell. Biol. 23:2709-2719.
10. Mizuno, S., Chijiwa, T., Okamura, T., Akashi, K., Fukumaki, Y., Niho, Y., and Sasaki, H. (2001). Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 97:1172-1179.
11. Montgomery, K. G., Liu, M. C., Eccles, D. M., and Campbell, I. G. (2004). The DNMT3B C → T promoter polymorphism and risk of breast cancer in a British population: Case-control study. Breast. Cancer Res. 6:390-394.
12. Okano, M., Bell, D. W., Haber, D. A., and Li, E. (1999). DNA methyltransferases Dnmt 3a and Dnmt 3b are essential for de novo methylation and mammalian development. Cell 99:247-257.
13. Patra, S. K., Patra, A., Zhao, H., and Dahiya, R. (2002). DNA methyltransferase and demethylase in human prostate cancer. Mol. Carcinog 33:163-171.
14. Robertson, K. D., Keyomarsi, K., Gonzales, F. A., Velicescu, M., and Jones, P. A. (2000). Differential mRNA expression of the human DNA methyltransferase (DNMTs) 1,3a and 3b during the G0/G1 to S phase transition in normal and tumor cells. Nucleic. Acids Res. 28:2108-2113.
15. Saito, Y., Kanai, Y., Nakagawa, T., Sakamoto, M., Saito, H., Ishii, H., and Hirohashi, S. (2003). Increased protein expression of DNA methyltransferase(DNMT)1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int. J. Cancer 105:527-532.
16. Shen, H., Wang, L., Spitz, M. R., Hong, W. K., Mao, L., and Wei, Q. (2002). A novel polymorphism in human cytosine DNA-methyltransferase 3B promoter is associated with an increased risk of lung cancer. Cancer Res. 2:4992-4995.
17. Sugimura, H., Kohno, T., and Wakai (1999). hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol. Biomark Prev. 8:669-674.
18. Toyooka, S., Maruyama, R., and Toyooka, K. O. (2003). Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int. J. Cancer 103:153-160.
19. Wang, L., Rodriguez, M., Kim, E. S., Xu, Y., Bekele, N., El-Nagger, A. K., Hong, W. K., and Oh, Y. W. (2004). A novel C/T polymorphism in the core promoter of human de novo cytosine DNA-methyltransferase 3B6 is associated with prognosis in head and neck cancer. Int. J. Oncol. 25:993-999.
20. Yakushiji, T., Uzawa, K., Shibahara, T., Nima, H., and Tanzawa, H. (2003). Overexpression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma. Int. J. Oncol. 22:1201-1207.